180 related articles for article (PubMed ID: 26448376)
1. How do I implement an automated screen for high-titer ABO antibody as an inventory management tool for ABO plasma-incompatible platelets?
Fontaine MJ; Webster J; Gomez S; Pham TD; Goodnough LT; Galel SA
Transfusion; 2015 Dec; 55(12):2783-9. PubMed ID: 26448376
[TBL] [Abstract][Full Text] [Related]
2. PAS-C platelets contain less plasma protein, lower anti-A and anti-B titers, and decreased HLA antibody specificities compared to plasma platelets.
Weisberg SP; Shaz BH; Tumer G; Silliman CC; Kelher MR; Cohn CS
Transfusion; 2018 Apr; 58(4):891-895. PubMed ID: 29473178
[TBL] [Abstract][Full Text] [Related]
3. Easier said than done: ABO compatibility and D matching in apheresis platelet transfusions.
Dunbar NM; Katus MC; Freeman CM; Szczepiorkowski ZM
Transfusion; 2015 Aug; 55(8):1882-8. PubMed ID: 25757728
[TBL] [Abstract][Full Text] [Related]
4. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies.
Quillen K; Sheldon SL; Daniel-Johnson JA; Lee-Stroka AH; Flegel WA
Transfusion; 2011 Jan; 51(1):92-6. PubMed ID: 20576015
[TBL] [Abstract][Full Text] [Related]
5. ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions.
Karafin MS; Blagg L; Tobian AA; King KE; Ness PM; Savage WJ
Transfusion; 2012 Oct; 52(10):2087-93. PubMed ID: 22339320
[TBL] [Abstract][Full Text] [Related]
6. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies.
Josephson CD; Castillejo MI; Grima K; Hillyer CD
Transfus Apher Sci; 2010 Feb; 42(1):83-8. PubMed ID: 20034854
[TBL] [Abstract][Full Text] [Related]
7. Factors affecting platelet yield and their impact on the platelet increment of patients receiving single donor PLT transfusion.
Enein AA; Hussein EA; El Shafie S; Hallouda M
J Clin Apher; 2007 Feb; 22(1):5-9. PubMed ID: 17266120
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis after ABO-incompatible platelet transfusions.
Chow MP; Yung CH; Hu HY; Tzeng CH
Zhonghua Yi Xue Za Zhi (Taipei); 1991 Aug; 48(2):131-4. PubMed ID: 1654184
[TBL] [Abstract][Full Text] [Related]
9. Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
Daniel-Johnson J; Leitman S; Klein H; Alter H; Lee-Stroka A; Scheinberg P; Pantin J; Quillen K
Transfusion; 2009 Sep; 49(9):1845-9. PubMed ID: 19453987
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of changes in hemoglobin levels associated with ABO-incompatible plasma in apheresis platelets.
Mair B; Benson K
Transfusion; 1998 Jan; 38(1):51-5. PubMed ID: 9482394
[TBL] [Abstract][Full Text] [Related]
11. Incompatible crossmatch: First sign of a hemolytic transfusion reaction due to out-of-group platelet transfusion.
Basu D; Basu S; Roy J; Reddy M; Chandy M; Bhaumik J
Asian J Transfus Sci; 2019; 13(1):57-59. PubMed ID: 31360013
[TBL] [Abstract][Full Text] [Related]
12. Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Opelz G; Morath C; Süsal C; Tran TH; Zeier M; Döhler B
Transplantation; 2015 Feb; 99(2):400-4. PubMed ID: 25050471
[TBL] [Abstract][Full Text] [Related]
13. Seasonal variability is not observed in the rates of high anti-A and anti-B titers in plasma, apheresis platelet, and whole blood units tested by different methods.
Harm SK; Yazer MH; Bub CB; Cohn CS; Jacob EK; Kutner JM; Mair DC; Raval JS; Shaz BH; Ziman A; Dunbar NM;
Transfusion; 2019 Feb; 59(2):762-767. PubMed ID: 30548267
[TBL] [Abstract][Full Text] [Related]
14. Antibody removal before ABO-incompatible renal transplantation: how much plasma exchange is therapeutic?
Lawrence C; Galliford JW; Willicombe MK; McLean AG; Lesabe M; Rowan F; Papalois V; Regan F; Taube D
Transplantation; 2011 Nov; 92(10):1129-33. PubMed ID: 21959216
[TBL] [Abstract][Full Text] [Related]
15. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
Yazer MH; Raval JS; Triulzi DJ; Blumberg N
Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
[TBL] [Abstract][Full Text] [Related]
16. Preparation of single donor platelet with low antibody titers for all patients.
Romphruk AV; Cheunta S; Pakoate L; Kumpeera P; Sripara P; Paupairoj C; Romphruk A
Transfus Apher Sci; 2012 Apr; 46(2):125-8. PubMed ID: 22365668
[TBL] [Abstract][Full Text] [Related]
17. When O Bites Back: Unrecognized Acute Hemolytic Reaction from Out-of-Group HLA-Compatible Platelet Transfusion.
Pasion JO; Song LH; McCusker MG; Shimer L; Bryant A; McGann HL; Fontaine MJ
Ann Clin Lab Sci; 2021 Mar; 51(2):267-270. PubMed ID: 33941569
[TBL] [Abstract][Full Text] [Related]
18. ABO antibody titer performance characteristics and correlates between two automated platforms.
Corean J; Gilsdorf J; Sauter J; Pamukcu P; Thorpe S; Pham T
Transfus Apher Sci; 2021 Dec; 60(6):103262. PubMed ID: 34483036
[TBL] [Abstract][Full Text] [Related]
19. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
Fontaine MJ; Kuo J; Chen G; Galel SA; Miller E; Sequeira F; Viele M; Goodnough LT; Tyan DB
Transfusion; 2011 Dec; 51(12):2611-8. PubMed ID: 21615749
[TBL] [Abstract][Full Text] [Related]
20. Impact of the baseline anti-A/B antibody titer on the clinical outcome in ABO-incompatible kidney transplantation.
Chung BH; Lim JU; Kim Y; Kim JI; Moon IS; Choi BS; Park CW; Kim YS; Yang CW
Nephron Clin Pract; 2013; 124(1-2):79-88. PubMed ID: 24157458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
